Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis
Chongshu Jian, Jiajun Fu, Xu Cheng, et al.
Cell Metabolism (2020) Vol. 31, Iss. 5, pp. 892-908.e11
Open Access | Times Cited: 135

Showing 1-25 of 135 citing articles:

Cordycepin Ameliorates Nonalcoholic Steatohepatitis by Activation of the AMP‐Activated Protein Kinase Signaling Pathway
Tian Lan, Yu Yang, Jing Zhang, et al.
Hepatology (2021) Vol. 74, Iss. 2, pp. 686-703
Open Access | Times Cited: 113
Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models
Ornella Urzì, Roberta Gasparro, Elisa Costanzo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12046-12046
Open Access | Times Cited: 48
Futile cycles: Emerging utility from apparent futility
Anand K. Sharma, Radhika Khandelwal, Christian Wolfrum
Cell Metabolism (2024) Vol. 36, Iss. 6, pp. 1184-1203
Open Access | Times Cited: 25
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH
Liang Tao, Xinquan Yang, Chaodong Ge, et al.
Cell Metabolism (2024) Vol. 36, Iss. 10, pp. 2190-2206.e5
Open Access | Times Cited: 20
The transcription factor ChREBP Orchestrates liver carcinogenesis by coordinating the PI3K/AKT signaling and cancer metabolism
Emmanuel Bénichou, Bolaji Seffou, Selin Topçu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Exploring the therapeutic potential of mitochondrial uncouplers in cancer
Riya Shrestha, Edward M. Johnson, Frances L. Byrne
Molecular Metabolism (2021) Vol. 51, pp. 101222-101222
Open Access | Times Cited: 88
From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases
Peng Zhao, Alan R. Saltiel
Journal of Biological Chemistry (2020) Vol. 295, Iss. 34, pp. 12279-12289
Open Access | Times Cited: 73
Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH
Leigh Goedeke, Gerald I. Shulman
Molecular Metabolism (2021) Vol. 46, pp. 101178-101178
Open Access | Times Cited: 71
Tripartite motif 16 ameliorates nonalcoholic steatohepatitis by promoting the degradation of phospho-TAK1
Lin Wang, Xin Zhang, Zhibin Lin, et al.
Cell Metabolism (2021) Vol. 33, Iss. 7, pp. 1372-1388.e7
Open Access | Times Cited: 71
Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation
Paul Middleton, Nikhil Vergis
Therapeutic Advances in Gastroenterology (2021) Vol. 14
Open Access | Times Cited: 65
Breviscapine alleviates NASH by inhibiting TGF‐β‐activated kinase 1‐dependent signaling
Tian Lan, Shuo Jiang, Jing Zhang, et al.
Hepatology (2021) Vol. 76, Iss. 1, pp. 155-171
Open Access | Times Cited: 63
Exploring the potential mechanism of Rhodomyrtus tomentosa (Ait.) Hassk fruit phenolic rich extract on ameliorating nonalcoholic fatty liver disease by integration of transcriptomics and metabolomics profiling
Ruimin Wang, Linling Yao, Xue Lin, et al.
Food Research International (2021) Vol. 151, pp. 110824-110824
Closed Access | Times Cited: 58
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism
Jelena Krstić, Isabel Reinisch, Katharina Schindlmaier, et al.
Science Advances (2022) Vol. 8, Iss. 3
Open Access | Times Cited: 53
A Photoactivated Sorafenib-Ruthenium(II) Prodrug for Resistant Hepatocellular Carcinoma Therapy through Ferroptosis and Purine Metabolism Disruption
Yidan Lai, Nong Lu, Shuangling Luo, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 19, pp. 13041-13051
Closed Access | Times Cited: 50
Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy
Zaigang Zhou, Jiashe Chen, Yu Liu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4204-4223
Open Access | Times Cited: 45
Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
Jorge Gutiérrez‐Cuevas, Silvia Lucano‐Landeros, Daniel López-Cifuentes, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 23-23
Open Access | Times Cited: 39
DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates
Pengxiang Qu, Oren Rom, Ke Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 5, pp. 742-757.e10
Open Access | Times Cited: 38
Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer
Tian‐Jiao Zhou, Mengmeng Zhang, Danmeng Liu, et al.
Biomaterials (2023) Vol. 305, pp. 122447-122447
Closed Access | Times Cited: 32
Cdo1-Camkk2-AMPK axis confers the protective effects of exercise against NAFLD in mice
Min Chen, Jieying Zhu, Wang-Jing Mu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27
Microfluidics‐enabled Serial Assembly of Lipid‐siRNA‐sorafenib Nanoparticles for Synergetic Hepatocellular Carcinoma Therapy
Yao Chen, Dong Zhao, Feng Xiao, et al.
Advanced Materials (2023) Vol. 35, Iss. 13
Closed Access | Times Cited: 25
Hepatic mitochondrial reductive stress in the pathogenesis and treatment of steatotic liver disease
M Jokinen, Panu K. Luukkonen
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 4, pp. 319-334
Open Access | Times Cited: 9
Hepatoprotective effects of polysaccharide from Morchella esculenta are associated with activation of the AMPK/Sirt1 signaling pathway in mice with NAFLD
Dandan Wang, Menglian Zhang, Yaowen Zhang, et al.
International Journal of Biological Macromolecules (2025) Vol. 301, pp. 140444-140444
Closed Access | Times Cited: 1
Mitochondrial targeted therapy in MAFLD
Sien Lai, Dongsheng Tang, Juan Feng
Biochemical and Biophysical Research Communications (2025) Vol. 753, pp. 151498-151498
Closed Access | Times Cited: 1
Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate–Activated Protein Kinase Signaling Pathway
Juan Wan, Yanyan Zhang, Diqi Yang, et al.
Hepatology (2021) Vol. 74, Iss. 6, pp. 3074-3090
Closed Access | Times Cited: 55
TMBIM1 is an inhibitor of adipogenesis and its depletion promotes adipocyte hyperplasia and improves obesity-related metabolic disease
Guang‐Nian Zhao, Zheng‐Wei Tian, Tian Tian, et al.
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1640-1654.e8
Open Access | Times Cited: 46
Page 1 - Next Page

Scroll to top